Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma
Mayo Clinic
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Cedars-Sinai Medical Center
Mundipharma Research Limited
Pfizer
OHSU Knight Cancer Institute
Beth Israel Deaconess Medical Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Pennsylvania
Case Comprehensive Cancer Center
Celgene
Barbara Ann Karmanos Cancer Institute
Yale University
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Celgene
University of Maryland, Baltimore
Swiss Cancer Institute
Masonic Cancer Center, University of Minnesota
University of California, Davis
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
California Cancer Consortium
Massachusetts General Hospital
University of Louisville
Amgen
Dana-Farber Cancer Institute
University of Pennsylvania
Alliance for Clinical Trials in Oncology
University Health Network, Toronto
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Celgene
University Health Network, Toronto
Indiana University
Indiana University